Anbarasu Kumaraswamy

机构：University of Michigan, Michigan Medicine · ORCID：0000-0002-9997-7430

发表论文 45 篇 · 总被引 489 次 · h-index 10

代表论文

• LSD1 promotes prostate cancer reprogramming by repressing TP53 signaling independently of its demethylase function (2023 · JCI Insight · 被引 43)
• PROX1 is an early driver of lineage plasticity in prostate cancer (2025 · Journal of Clinical Investigation · 被引 10)
• Transcriptional profiling clarifies a program of enzalutamide extreme non-response in lethal prostate cancer (2025 · npj Precision Oncology · 被引 1)
• LSD1+8a is an RNA biomarker of neuroendocrine prostate cancer (2025 · Neoplasia · 被引 1)
• Study of JAK inhibition in stem-like prostate cancer (JASPER): A phase 1/2 multicenter study of ruxolitinib and enzalutamide in castration resistant prostate cancer undergoing lineage plasticity. (2025 · Journal of Clinical Oncology · 被引 1)
• Combined BET bromodomain and DNMT inhibition targets critical survival pathways in transdifferentiated prostate cancer (2026 · JCI Insight)